Chapter 7 (A case study of patients' organizations: between good causes and hidden clients) provides empirical traction to a nascent literature that has called attention to the potential influence of transnational pharmaceutical companies in the surge of right-to-health litigiousness in some Latin American countries. Furthermore, I present a case study of the multifaceted linkages between patients' organizations that provide pro bono litigation support and transnational pharmaceutical companies. The findings of this chapter are the result of an in-depth immersion in the practice of right-to-health litigation. The "thick narrative" of how actual litigants go about their work offers insights into the crisis of right-to-health litigation in Colombia and Brazil.
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your Elgar Online account
-
Front Matter
-
Part I: The transformations of the right to health
-
Part II: Local maladies: the epidemic of the right to health in Brazil and Colombia
-
Back Matter
